930 To William Budaeus.
Comment on egusphere-2023-930
930.html
Nr. 930
First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy Participants
渋柿 (930)
C20H26O5 - Structure No. 930
EP report (930)
930 Diamagnetic susceptibility of C22H22FeN6O3
Präsidialverfügung 930 vom 03.06.1954